郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Structure-Based Design and Discovery of New M2 Receptor Agonists.

期刊：Journal of medicinal chemistry发表年份：2017作者：Inbar Fish; Anne Stößel; Katrin Eitel; Celine Valant; Sabine Albold; Harald Huebner; Dorothee Möller; Mary J Clark; Roger K Sunahara; Arthur Christopoulos; Brian K Shoichet; Peter Gmeiner
阅读更多 →

药效评价Complex action of tyramine, tryptamine and histamine on native and recombinant ASICs.

期刊：Channels (Austin, Tex.)发表年份：2017作者：Oleg I Barygin; Margarita S Komarova; Tatyana B Tikhonova; Anastasiia S Korosteleva; Maxim V Nikolaev; Lev G Magazanik; Denis B Tikhonov
阅读更多 →

药效评价Sialylated glycosylphosphatidylinositols suppress the production of toxic amyloid-β oligomers.

期刊：The Biochemical journal发表年份：2017作者：William Nolan; Harriet McHale-Owen; Clive Bate
阅读更多 →

药效评价FTBMT, a Novel and Selective GPR52 Agonist, Demonstrates Antipsychotic-Like and Procognitive Effects in Rodents, Revealing a Potential Therapeutic Agent for Schizophrenia.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2017作者：Keiji Nishiyama; Hirobumi Suzuki; Toshiya Harasawa; Noriko Suzuki; Emi Kurimoto; Takayuki Kawai; Minoru Maruyama; Hidetoshi Komatsu; Kensuke Sakuma; Yuji Shimizu; Masato Shimojo
阅读更多 →